Gujarat Alkalies and Chemicals (GUJALKALI) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
20 Oct, 2026Executive summary
Q1 FY26 returned to standalone profitability: PBT ₹9.55 crore and PAT ₹7.79 crore, versus losses of ₹30.44 crore and ₹24.69 crore YoY; EBITDA rose to ₹125.09 crore from ₹77.07 crore.
Sales revenue was ₹1,073 crore, up ₹122.28 crore (12.86%) YoY, supported by higher capacity utilization, production and sales realization across major product groups.
Financial highlights
Standalone revenue from operations was ₹1,105.12 crore versus ₹977.30 crore in Q1 FY25; total income was ₹1,113.59 crore versus ₹980.60 crore.
Standalone total expenses were ₹1,104.04 crore versus ₹1,011.04 crore YoY; quarterly PBT was ₹9.55 crore versus a loss of ₹30.44 crore, and PAT was ₹7.79 crore versus a loss of ₹24.69 crore.
Consolidated PBT was a loss of ₹12.02 crore and PAT a loss of ₹13.78 crore, compared with losses of ₹50.28 crore and ₹44.53 crore, respectively, in Q1 FY25.
Consolidated total comprehensive income was ₹189.58 lakh versus ₹2,944.60 lakh in Q1 FY25; the current-quarter figure includes a ₹681.04 lakh notional gain from JV CCD liability revaluation.
Outlook and guidance
Continued energy-cost improvement initiatives are planned through FY26 and FY27, following improved renewable-energy power use of 32%–35% in Q1.
Project Ahvaan targets operating efficiency, cost reduction, increased green energy and long-term growth; initiatives include improving renewable-asset throughput and sourcing short-term renewable power competitively.
Initiatives under Project Ahvaan are expected to support operational efficiency in the short to long term; A T Kearney was engaged as strategic consultant.
Latest events from Gujarat Alkalies and Chemicals
- EBITDA advanced as nine-month consolidated losses narrowed and major projects gained approval.GUJALKALI
Q3 25/26 - Standalone H1 swung to loss; JV losses deepened the consolidated decline.GUJALKALI
Q2 23/24 - FY24 losses replaced prior-year profits, alongside a special dividend recommendation.GUJALKALI
Q4 23/24 - FY26 EBITDA rose 15%, while consolidated losses narrowed and expansion plans advanced.GUJALKALI
Q4 25/26 - Standalone profits rebounded as EBITDA doubled, but JV losses kept consolidated results negative.GUJALKALI
Q4 24/25 - Q2 profit recovery coincided with pay-revision and fire costs, plus new renewable-power plans.GUJALKALI
Q2 25/26 - H1 losses narrowed, while captive renewable power plans advanced.GUJALKALI
Q2 24/25 - Higher Q3 revenue and positive standalone PAT, but consolidated losses persisted.GUJALKALI
Q3 24/25 - Revenue rose, but standalone and consolidated results remained loss-making.GUJALKALI
Q1 24/25